• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE DEFIBRILLATION LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE DEFIBRILLATION LEAD Back to Search Results
Model Number 0293
Device Problems Failure to Capture (1081); Over-Sensing (1438); Pacing Problem (1439); Pocket Stimulation (1463); Failure to Select Signal (1582); Low impedance (2285); Device Sensing Problem (2917); Material Integrity Problem (2978)
Patient Problem Muscle Stimulation (1412)
Event Date 12/07/2018
Event Type  Injury  
Event Description
It was reported that this right ventricular (rv) lead exhibited low amplitude, noise, oversensing, pacing inhibition, and loss of capture.The patient experienced chest and pocket stimulation.It was noted the impedances had decreased from 700 ohms at implant to 601 ohms.Fluoroscopy was performed and the lead was still in the rv apex.Subsequently, a revision procedure was performed and the rv lead was explanted and replaced.There were two cuts noted in the lead body.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection revealed several cuts in the insulation through to all lumens.This type of damage is consistent with damage induced during the explant procedure.Testing was completed to assess lead electrical performance and inner insulation integrity.Measurements throughout these tests were within normal limits.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported low amplitude, loss of capture, low impedances, noise, oversensing, and pacing inhibition.
 
Event Description
This supplemental report is being filed as the device evaluation was completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Type of Device
IMPLANTABLE DEFIBRILLATION LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8275169
MDR Text Key134010766
Report Number2124215-2019-00786
Device Sequence Number1
Product Code NVY
UDI-Device Identifier00802526531255
UDI-Public00802526531255
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/05/2020
Device Model Number0293
Device Catalogue Number0293
Device Lot Number431961
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2018
Date Manufacturer Received02/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age72 YR
-
-